Home›Stock Screener›Citurgia Biochemicals

Citurgia Biochemicals Share Price Today | Stock Price & Citurgia Biochemicals Share Screener

CITURGIA Commodity Chemicals
Live Share Price BSE
₹104.45
▼ -1.05 (-1.00%)
2026-09-28 00:00:00

As of September 28, 2026, the live Citurgia Biochemicals share price (BSE: CITURGIA) is ₹104.45, down 1.00% from the previous close, with shares trading between ₹104.45 and ₹105.50 in today's trading session, and a 52-week range of ₹49.77–₹203.35. Check CITURGIA annual price range for the annual price range and momentum. Use the Citurgia Biochemicals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Citurgia Biochemicals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Citurgia Biochemicals Market Cap ₹1,567.95 Cr.
CITURGIA P/E Ratio (TTM) -
Citurgia Biochemicals P/B Ratio -156.31
EPS (TTM) ₹-0.16
Dividend Yield -
Debt to Equity -
CITURGIA 52 Week High ₹203.35
Citurgia Biochemicals 52 Week Low ₹49.77
Operating Margin -
Profit Margin -
CITURGIA Revenue (TTM) -
EBITDA -
Net Income ₹-1.00
Total Assets ₹11.00
Total Equity ₹-7.00

Citurgia Biochemicals Share Price Chart

Track the current stock price of Citurgia Biochemicals with an interactive chart. Analyse CITURGIA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Citurgia Biochemicals stock quote in one place.

The quote of ₹104.45 sits between the 52-week low of ₹49.77 and the 52-week high of ₹203.35, and the latest session moved -1.00% from the previous close.

Citurgia Biochemicals Company Profile - Fundamental Screener

Screen Citurgia Biochemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CITURGIA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Commodity Chemicals industry, and it trades under ISIN INE795B01031.

Company Details

Classification

Sector Chemicals
Industry Commodity Chemicals
Sub-Sector Commodity Chemicals
Segment E

Identifiers and Leadership

ISIN INE795B01031

Citurgia Biochemicals Balance Sheet Screener

Screen CITURGIA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹11, down from ₹11 in 2024.

Latest statistics put total assets at ₹11 and shareholder funds at ₹-7.

Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

Assets

Total Assets 11 11 11 11 12 12 12 13 12 12
Current Assets 8 8 8 8 8 8 8 8 7 6
Fixed Assets 1 1 1 1 2 2 2 2 3 3

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 9 9 8 8 8 8 8 8 7 6
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity -7 -7 -6 -6 -5 -5 -4 -4 -3 -3
Share Capital 26 26 26 26 26 26 26 26 26 26
Reserves & Surplus -36 -36 -35 -35 -34 -34 -33 -33 -32 -32

Citurgia Biochemicals Income Statement Screener - Profit & Revenue Analysis

Screen Citurgia Biochemicals income statement and profit fundamentals. Analyze CITURGIA quarterly results. Citurgia Biochemicals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹-1.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹0 and net profit of ₹0.

Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0

Operating Costs and Margins

EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
Operating Profit % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax -1 0 -1 0 0 -1 0 -1 -1 -1 -1 -1
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit -1 0 -1 0 0 -1 0 -1 -1 -1 -1 -1
EPS 0.00 -0.16 -0.18 -0.17 -0.15 -0.23 -0.15 -0.21 -0.21 -0.20 -0.25 -0.29

Citurgia Biochemicals Cash Flow Screener - Liquidity Fundamentals

Screen CITURGIA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹0.

Over the same period, investing activities provided ₹0 and financing activities provided ₹0.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities 0 0 0 0 0 0 0 -1 -1 0
Investing Activities 0 0 0 0 0 0 0 0 0 0

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 0 1 1 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 0

Citurgia Biochemicals Shareholding Pattern Screener

See Citurgia Biochemicals shareholding pattern with promoter, FII, and DII holdings. Check Citurgia Biochemicals promoter holding and ownership changes for CITURGIA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 99.36%, foreign institutions 0.00%, domestic institutions 0.00% and the public 0.30%, spread across 5,767 shareholders.

The shareholder count was 5,767 in 2026-Mar, compared with 5,383 in 2025-Mar.

Item 2026-Mar 2025-Mar 2025-May 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 99.36% 99.67% 99.36% 99.36% 99.36% 99.36% 99.67% 99.67%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 0.30% 0.29% 0.34% 0.34% 0.34% 0.34% 0.29% 0.29%
Other Holding 0.33% 0.03% 0.30% 0.30% 0.30% 0.30% 0.03% 0.03%
Shareholder Count 5,767 5,383 5,383 5,383 5,383 5,383 5,383 5,383

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Citurgia Biochemicals. Citurgia Biochemicals dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Citurgia Biochemicals.

Citurgia Biochemicals Stock Index Membership - Nifty & Sensex

See which indices include Citurgia Biochemicals stock. Check CITURGIA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Citurgia Biochemicals is not part of any tracked indices.
Only major market indices are tracked in our system.

Citurgia Biochemicals Market Events Screener - Corporate Actions

Get Citurgia Biochemicals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Citurgia Biochemicals stock events that may affect CITURGIA share price, along with derivatives, futures and options activity and sector gainers.

10 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated May 30, 2026, with a record date of May 30, 2026.

It is followed by Quarterly Result Announcement dated February 14, 2026 and Quarterly Result Announcement dated November 14, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-05-30 2026-05-30 Quarterly Result Announcement NA 12.59%
2026-02-14 2026-02-14 Quarterly Result Announcement NA -
2025-11-14 2025-11-14 Quarterly Result Announcement NA -
2025-09-27 2025-09-27 Annual General Meeting NA -
2025-08-14 2025-08-14 Quarterly Result Announcement NA -
2025-05-30 2025-05-30 Quarterly Result Announcement NA -
2025-02-14 2025-02-14 Quarterly Result Announcement NA -
2024-11-14 2024-11-14 Quarterly Result Announcement NA -
2024-09-30 2024-09-30 Annual General Meeting NA -
2023-09-30 2023-09-30 Annual General Meeting NA -

Citurgia Biochemicals Competitors Screener - Peer Stocks Comparison

Screen CITURGIA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Tata Chemicals 19,732 -11.65 14,584 -3.49% -1,631 57.34
Deepak Fertilisers & Petrochemicals 18,283 20.83 10,355 17.69% 945 68.03
Gujarat Narmada Valley Fert & Chem 7,584 9.41 7,773 -7.39% 753 58.08
Gujarat Alkalies & Chemicals 5,048 -594.66 4,165 6.89% -65 47.88
GHCL 4,257 8.92 3,064 -6.33% 481 44.64
TANFAC Industries 3,990 56.35 711 27.00% 73 31.67
Chemplast Sanmar 3,514 -13.06 4,224 -3.85% -372 40.78
Grauer & Weil 3,277 24.30 1,190 0.86% 168 55.89
Thirumalai Chemicals 2,574 -16.66 2,070 -1.54% -46 57.53
Fischer Medical Ventures 2,429 62.45 112 421.86% 1 53.06

Citurgia Biochemicals Company Announcements - News & Reports Screener

Screen CITURGIA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 27, 2026.

The next most recent announcements are dated April 21, 2026 and April 6, 2026.

Date Update Actions
2026-09-27 Board Meeting Intimation for Consider And Approve Audited Financial Results (Standalone) For The Quarter And Year Ended March 31 2026. -
2026-04-21 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-06 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate -
2026-03-31 Closure of Trading Window -
2026-02-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-14 UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED ON 31.12.2025 -
2026-02-05 Board Meeting Intimation for Consider And Approve Unaudited Financial Result For The Quarter Ended On 31.12.2025 -
2026-01-02 Closure of Trading Window -
2025-12-23 Appointment of Company Secretary and Compliance Officer -
2025-11-21 Results-Delay in Financial Results -
2025-11-07 Board Meeting Intimation for Consider And Approve Unaudited Financial Results (Standalone) For The Quarter And Half Year Ended September 30 2025. -
2025-10-06 Reg. 34 (1) Annual Report. -
2025-10-01 Closure of Trading Window -
2025-10-01 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-09-20 Intimation Of Book Closure -
2025-09-02 Board Meeting Outcome for OUTCOME OF BOARD MEETING -
2025-08-26 Update on board meeting -
2025-08-26 Results-Delay in Financial Results -
2025-08-26 Board Meeting Intimation for Consider And Approve For Dividing Of Annual General Meeting -
2025-08-26 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹104.45, within a 52-week range of ₹49.77 to ₹203.35. The P/B ratio is -156.31. Market capitalisation stands at ₹1,567.95 Cr. The company operates in the Chemicals sector, in the Commodity Chemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.